Zeranol may increase the risk of leptin-induced neoplasia in human breast

Xu,Pingping; Ye,Weiping; Zhong,Saiyi; Jen,Robert; Li,Hong; Feng,Eric; Lin,Shu-Hong; Liu,Jie-Yu; Lin,Young  C.

doi:10.3892/ol.2010.214

Zeranol may increase the risk of leptin-induced neoplasia in human breast

Authors:
- Pingping Xu
- Weiping Ye
- Saiyi Zhong
- Robert Jen
- Hong Li
- Eric Feng
- Shu-Hong Lin
- Jie-Yu Liu
- Young C. Lin
View Affiliations

Affiliations: Laboratory of Reproductive and Molecular Endocrinology, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA
Published online on: November 23, 2010 https://doi.org/10.3892/ol.2010.214
Pages: 101-108

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Breast cancer and obesity are serious health problems and their relationship has been studied for many years. Leptin is mainly secreted by adipocytes and plays a key role in breast cancer development. Leptin expression is up-regulated in obese individuals and promotes breast cancer cell growth. On the other hand, exposure to environmental estrogens has been found to be directly related to breast cancer. Zeranol (Z) is a non-steroidal anabolic growth promoter used in the beef industry in the US. This study focused on the evaluation of Z and Z-containing sera (ZS) and its adverse health risk to human consumption of Z-containing meat produced from Z-implanted beef cattle. We hypothesized that Z increases the risk of breast neoplasia in women, particularly in obese women. A cell proliferation assay, ELISA analysis, RT-PCR and Western blot analysis were conducted. Our study demonstrated that Z and ZS collected from Z-implanted heifers stimulated the proliferation of primary cultured human normal breast epithelial cells (HNBECs) by up-regulating cyclin D1 expression. Leptin increased the sensitivity of HNBECs to Z, and Z increased the ability of HNBECs to secrete leptin. These results suggest an interaction between leptin and Z in HNBECs. Furthermore, Z may play a role in leptin-induced breast neoplasia.

View Figures

View References

1	Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin. 59:225–249. 2009.
2	Calle EE and Thun MJ: Obesity and cancer. Oncogene. 23:6365–6378. 2004. View Article : Google Scholar
3	Garofalo C and Surmacz E: Leptin and cancer. J Cell Physiol. 207:12–22. 2006. View Article : Google Scholar
4	Lorincz AM and Sukumar S: Molecular links between obesity and breast cancer. Endocr Relat Cancer. 13:279–292. 2006. View Article : Google Scholar : PubMed/NCBI
5	De Waard F, Baanders-Vanhalewijn EA and Huizinga J: The bimodal age distribution of patients with mammary carcinoma; evidence for the existence of 2 types of human breast cancer. Cancer. 17:141–151. 1964.PubMed/NCBI
6	Zhang Y, Proenca R, Maffei M, Barone M, Leopold L and Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
7	Rosen ED and Spiegelman BM: Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 444:847–853. 2006. View Article : Google Scholar : PubMed/NCBI
8	Kiess W, Petzold S, Topfer M, et al: Adipocytes and adipose tissue. Best Pract Res Clin Endocrinol Metab. 22:135–153. 2008. View Article : Google Scholar
9	Clement K, Vaisse C, Lahlou N, et al: A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 392:398–401. 1998. View Article : Google Scholar : PubMed/NCBI
10	Buschemeyer WC III and Freedland SJ: Obesity and prostate cancer: epidemiology and clinical implications. Eur Urol. 52:331–343. 2007. View Article : Google Scholar : PubMed/NCBI
11	Caldefie-Chezet F, Damez M, de Latour M, et al: Leptin: a proliferative factor for breast cancer? Study on human ductal carcinoma. Biochem Biophys Res Commun. 334:737–741. 2005. View Article : Google Scholar : PubMed/NCBI
12	Rose DP, Komninou D and Stephenson GD: Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev. 5:153–165. 2004. View Article : Google Scholar : PubMed/NCBI
13	Ishikawa M, Kitayama J and Nagawa H: Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res. 10:4325–4331. 2004. View Article : Google Scholar : PubMed/NCBI
14	Laud K, Gourdou I, Pessemesse L, Peyrat JP and Djiane J: Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol. 188:219–226. 2002. View Article : Google Scholar : PubMed/NCBI
15	Calle EE, Rodriguez C, Walker-Thurmond K and Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 348:1625–1638. 2003. View Article : Google Scholar : PubMed/NCBI
16	Garofalo C, Sisci D and Surmacz E: Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells. Clin Cancer Res. 10:6466–6475. 2004. View Article : Google Scholar : PubMed/NCBI
17	Catalano S, Mauro L, Marsico S, et al: Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. J Biol Chem. 279:19908–19915. 2004. View Article : Google Scholar : PubMed/NCBI
18	Frankenberry KA, Skinner H, Somasundar P, McFadden DW and Vona-Davis LC: Leptin receptor expression and cell signaling in breast cancer. Int J Oncol. 28:985–993. 2006.PubMed/NCBI
19	Saxena NK, Vertino PM, Anania FA and Sharma D: Leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem. 282:13316–13325. 2007. View Article : Google Scholar
20	Catalano S, Marsico S, Giordano C, Mauro L, Rizza P, Panno ML and Ando S: Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J Biol Chem. 278:28668–28676. 2003. View Article : Google Scholar : PubMed/NCBI
21	Yin N, Wang D, Zhang H, et al: Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res. 64:5870–5875. 2004. View Article : Google Scholar : PubMed/NCBI
22	Goodwin PJ, Ennis M, Fantus IG, Pritchard KI, Trudeau ME, Koo J and Hood N: Is leptin a mediator of adverse prognostic effects of obesity in breast cancer? J Clin Oncol. 23:6037–6042. 2005. View Article : Google Scholar : PubMed/NCBI
23	Cirillo D, Rachiglio AM, la Montagna R, Giordano A and Normanno N: Leptin signaling in breast cancer: an overview. J Cell Biochem. 105:956–964. 2008. View Article : Google Scholar : PubMed/NCBI
24	Chen C, Chang YC, Liu CL, Chang KJ and Guo IC: Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Breast Cancer Res Treat. 98:121–132. 2006. View Article : Google Scholar : PubMed/NCBI
25	Garofalo C, Koda M, Cascio S, et al: Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res. 12:1447–1453. 2006. View Article : Google Scholar
26	Thorn SR, Meyer MJ, Van Amburgh ME and Boisclair YR: Effect of estrogen on leptin and expression of leptin receptor transcripts in prepubertal dairy heifers. J Dairy Sci. 90:3742–3750. 2007. View Article : Google Scholar : PubMed/NCBI
27	Ozet A, Arpaci F, Yilmaz MI, et al: Effects of tamoxifen on the serum leptin level in patients with breast cancer. Jpn J Clin Oncol. 31:424–427. 2001. View Article : Google Scholar : PubMed/NCBI
28	Coe JE, Ishak KG, Ward JM and Ross MJ: Tamoxifen prevents induction of hepatic neoplasia by zeranol, an estrogenic food contaminant. Proc Natl Acad Sci USA. 89:1085–1089. 1992. View Article : Google Scholar : PubMed/NCBI
29	Liu S and Lin YC: Transformation of MCF-10A human breast epithelial cells by zeranol and estradiol-17beta. Breast J. 10:514–521. 2004. View Article : Google Scholar : PubMed/NCBI
30	Takemura H, Shim JY, Sayama K, Tsubura A, Zhu BT and Shimoi K: Characterization of the estrogenic activities of zearalenone and zeranol in vivo and in vitro. J Steroid Biochem Mol Biol. 103:170–177. 2007. View Article : Google Scholar : PubMed/NCBI
31	Ye W, Xu P, Threlfall WR, et al: Zeranol enhances the proliferation of pre-adipocytes in beef heifers. Anticancer Res. 29:5045–5052. 2009.PubMed/NCBI
32	Narro LA, Thomas MG, Silver GA, Rozeboom KJ and Keisler DH: Body composition, leptin, and the leptin receptor and their relationship to the growth hormone (GH) axis in growing wethers treated with zeranol. Domest Anim Endocrinol. 24:243–255. 2003. View Article : Google Scholar : PubMed/NCBI
33	Yuri T, Tsukamoto R, Miki K, Uehara N, Matsuoka Y and Tsubura A: Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells. Oncol Rep. 16:1307–1312. 2006.PubMed/NCBI
34	Liu S, Sugimoto Y, Sorio C, Tecchio C and Lin YC: Function analysis of estrogenically regulated protein tyrosine phosphatase gamma (PTPgamma) in human breast cancer cell line MCF-7. Oncogene. 23:1256–1262. 2004. View Article : Google Scholar : PubMed/NCBI
35	Gilbert NE, O’Reilly JE, Chang CJ, Lin YC and Brueggemeier RW: Antiproliferative activity of gossypol and gossypolone on human breast cancer cells. Life Sci. 57:61–67. 1995. View Article : Google Scholar : PubMed/NCBI
36	Ye W, Chang HL, Wang LS, et al: Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil. Anticancer Res. 27:107–116. 2007.PubMed/NCBI
37	Xu P, Ye W, Jen R, Lin SH, Kuo CT and Lin YC: Mitogenic activity of zeranol in human breast cancer cells is enhanced by leptin and suppressed by gossypol. Anticancer Res. 29:4621–4628. 2009.PubMed/NCBI
38	Lorincz AM and Sukumar S: Molecular links between obesity and breast cancer. Endocr Relat Cancer. 13:279–292. 2006. View Article : Google Scholar : PubMed/NCBI
39	Roy PG and Thompson AM: Cyclin D1 and breast cancer. Breast. 15:718–727. 2006. View Article : Google Scholar : PubMed/NCBI